Furosemide (Lasix) in Congestive Heart Failure Management
Furosemide is the cornerstone diuretic for CHF and should be prescribed to all patients with current or prior evidence of fluid retention, combined with an ACE inhibitor, beta-blocker, and aldosterone antagonist. 1
Essential Role and Mechanism
Furosemide is FDA-approved for treating edema associated with congestive heart failure and is particularly useful when greater diuretic potential is desired. 2, 3 Loop diuretics like furosemide are preferred over thiazides because they increase sodium excretion up to 20-25% of the filtered load, maintain efficacy even with impaired renal function, and enhance free water clearance. 1
Diuretics are the only drugs that can adequately control fluid retention in heart failure—ACE inhibitors and digitalis cannot substitute for diuretics in managing volume overload. 1
Initial Dosing Strategy
Oral Therapy for Stable CHF
- Start with furosemide 20-40 mg once or twice daily 1
- Increase the dose until urine output increases and weight decreases by 0.5-1.0 kg daily 1, 4
- Further increases in dose or frequency (twice-daily dosing) may be required to maintain active diuresis 1, 4
- Maximum daily dose can reach 600 mg, and occasionally higher in severe cases 1, 4
The ultimate goal is to eliminate all clinical evidence of fluid retention, including jugular venous distension and peripheral edema. 1
IV Therapy for Acute Decompensation
When rapid diuresis is needed or oral absorption is impaired: 2
- For diuretic-naïve patients: 20-40 mg IV furosemide 4
- For patients already on oral diuretics: initial IV dose should be at least equivalent to the oral dose 1, 4
- Can be administered as intermittent boluses or continuous infusion 4
- Replace with oral therapy as soon as practical 2
Maintenance and Monitoring
Dose Adjustment Algorithm
- Have patients record daily weights and adjust diuretic dose if weight increases or decreases beyond a specified range 1, 4
- Maintain treatment to prevent recurrence of volume overload, with frequent adjustments as needed 1, 4
- Aim for the lowest dose that maintains dry weight 1, 5
Critical Monitoring Parameters
- Daily weights to guide dose adjustments 4
- Renal function and electrolytes regularly, especially potassium and magnesium 1, 4
- Symptoms and urine output continuously during active diuresis 4, 5
Essential Concurrent Therapy
Diuretics should never be used alone in Stage C heart failure. 1 They must be combined with:
- ACE inhibitors or ARBs (continue during exacerbations unless hemodynamically unstable) 4
- Beta-blockers (continue during exacerbations unless hemodynamically unstable) 4
- Aldosterone antagonists 1
Inappropriate diuretic dosing undermines the efficacy of these other heart failure medications. 4
Managing Diuretic Resistance
If adequate diuresis is not achieved with loop diuretics alone:
- Consider adding a thiazide-type diuretic (metolazone 2.5-10 mg) or spironolactone 1, 5
- Monitor carefully for hypokalemia, renal dysfunction, and hypovolemia 4, 5
- High-dose furosemide (250-4000 mg/day) can be effective in refractory cases with reduced renal function 6
Special Considerations for Hypotension
In patients with SBP <90 mmHg, hold diuretics until adequate perfusion is restored, as they can worsen hypotension and end-organ perfusion. 4
- Look for signs of hypoperfusion: cool extremities, altered mental status, oliguria, elevated lactate, or worsening renal function 4
- Rule out hypovolemia or other correctable causes before considering inotropes 4
- Consider short-term IV inotropic support (dobutamine, dopamine, or levosimendan) if hypoperfusion persists despite adequate volume status 4
- Once perfusion is restored and SBP improves, initiate diuretic therapy with careful monitoring 4
Adverse Effects and Risks
Principal adverse effects include: 1
- Electrolyte depletion (potassium and magnesium), predisposing to arrhythmias
- Hypotension and azotemia
- Risk markedly enhanced when two diuretics are combined 1
Treat electrolyte imbalances aggressively while continuing diuresis. 4 If hypotension or azotemia occurs before treatment goals are achieved, slow the rate of diuresis but maintain it until fluid retention is eliminated. 4
Critical Pitfalls to Avoid
Inappropriately Low Doses
- Result in fluid retention 1
- Diminish response to ACE inhibitors 1, 4
- Increase risk of treatment with beta-blockers 1
Inappropriately High Doses
- Lead to volume contraction 1
- Increase risk of hypotension with ACE inhibitors and vasodilators 1, 4
- Increase risk of renal insufficiency with ACE inhibitors and ARBs 1
Excessive Concern About Side Effects
Excessive concern about hypotension and azotemia can lead to underutilization of diuretics and refractory edema. 4, 5 Optimal use of diuretics is the cornerstone of any successful approach to heart failure treatment. 1